Screener
Bristol-Myers Squibb BMY Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's invested capital?
- Bristol-Myers Squibb (BMY) reported invested capital of $56.92B in Q2 2026.
- How has Bristol-Myers Squibb's invested capital changed year-over-year?
- Bristol-Myers Squibb's invested capital increased by 5.0% year-over-year, from $54.22B to $56.92B.
- What is the long-term trend for Bristol-Myers Squibb's invested capital?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's invested capital has grown at a -5.8% compound annual growth rate (CAGR), from $74.7B to $55.4B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Bristol-Myers Squibb's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude